Sorry, you need to enable JavaScript to visit this website.
Search Hamburger menu
Search

Search Expertise

Search Services

Search Content

Search

Sort by

Most Relevant Most Recent A-Z
Filter
321 - 330 of 359 results

Results for

eval and methods

Evaluation & Methods Digest - February 2022

News
Default image

Winter Sports Are on Thin Ice -- This Snowboarder Wants To Preserve Their Future

News
Abt Global Awarded Climate Registered™ Platinum Status and Joins Ranks of U.S. Climate Leaders

Abt Global Awarded Climate Registered™ Platinum Status and Joins Ranks of U.S. Climate Leaders

News
Study Shows Pfizer Vaccine Is Moderately Effective Against Omicron for Children 5-15

Study Shows Pfizer Vaccine Is Moderately Effective Against Omicron for Children 5-15

News
A new CDC-Abt study using real-world data shows that the Pfizer-BioNTech COVID-19 vaccine is moderately effective for children ages 5-15.
equitable economics

Equitable Economies - March 2022

News
Abt’s latest insights on advancing inclusive economic growth for sustainable development.
environment energy

Climate, Energy and Environment - March 2022

News
Abt is committed to solving environmental challenges in a complex world. Dive into our latest news!
The Rules Come From Somewhere (with Dr. Cara Jackson)

The Rules Come From Somewhere (with Dr. Cara Jackson)

News
Default image

CDC-Abt Study Shows Pfizer Vaccine Is Moderately Effective for Children

News
global health

Global Health – March 2022

News
March 2022 - Learn how Abt's work around the world is creating easier access to family planning, stronger health systems, and more!
3rd COVID-19 Vaccine Dose Offers More Protection

3rd COVID-19 Vaccine Dose Offers More Protection

News
A study by Abt and its partners showed three COVID-19 vaccine doses are more effective than two but are less effective against Omicron than against Delta.